ULTRALIFE CORP — Director's Dealing 2019

Jul 25, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ULTRALIFE CORP (ULBI)
CIK: 0000875657
Period of Report: 2019-07-23

Reporting Person: POPIELEC MICHAEL D (Director, Director, President and CEO)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2019-07-23	Common Stock (Right to Buy)	$8.2523	A	45000	Acquired	2026-07-23	Common Stock (45000)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock; $.10 par value	270288	Direct

Footnotes

F1: These options vest as follows: 15,000 shares on 7-23-2020; 15,000 shares vest on 7-23-2021 and 15,000 shares vest on 7-23-2022.